Research Article
Association of Epidermal Growth Factor Receptor Mutations with Metastatic Presentations in Non-Small Cell Lung Cancer
Table 1
Patient characteristics ().
| Characteristic | Number of patients (%) |
| Age (years) | | Median | 63 (range, 28–83) | Gender | | Male | 87 (70) | Female | 38 (30) | Smoking history | | Never | 45 (36) | Ever | 80 (64) | Histopathology | | ADC* | 81 (65) | Other | 44 (35) | Tumor size (cm) | | Median | 4.2 (range, 1.0–10.0) | T stage | | T1-2 | 84 (67) | T3-4 | 41 (33) | N stage | | N0–2 | 86 (69) | N3 | 39 (31) | M Stage | | M0 | 43 (34) | M1 | 82 (66) | Metastatic sites | | Pleura | 26 (21) | PMME | 13 | Lung | 38 (30) | Brain () | 23 (19) | Bone () | 37 (30) | Liver | 7 (6) | Other† | 14 (11) |
|
|
Abbreviations: ADC, adenocarcinoma; PMME, pleural metastases with minimal effusion.
*Two bronchioloalveolar carcinomas. †Including nine adrenal gland metastases.
|